Viral latency locus augments B-cell response in vivo to induce chronic marginal zone enlargement, plasma cell hyperplasia, and lymphoma

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines

(2011) D. Roy et al.   BLOOD

Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case–control study

(2011) Y Benavente et al.   BRITISH JOURNAL OF CANCER

The latency-associated nuclear antigen, a multifunctional protein central to Kaposi’s sarcoma-associated herpesvirus latency

(2011) Mary E Ballestas et al.   Future Microbiology

Viral Latency and Its Regulation: Lessons from the γ-Herpesviruses

(2010) Samuel H. Speck et al.   Cell Host & Microbe

KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine

(2010) Don Ganem   JOURNAL OF CLINICAL INVESTIGATION

The Viral Latency-Associated Nuclear Antigen Augments the B-Cell Response to AntigenIn Vivo

(2010) Sang-Hoon Sin et al.   JOURNAL OF VIROLOGY

Immature and Transitional B Cells Are Latency Reservoirs for a Gammaherpesvirus

(2010) C. B. Coleman et al.   JOURNAL OF VIROLOGY

Human Herpesvirus-8 Infection Leads to Expansion of the Preimmune/Natural Effector B Cell Compartment

(2010) Silvia Della Bella et al.   PLoS One

Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation

(2008) Peter R Wilker et al.   NATURE IMMUNOLOGY